SEP
05

CLEAR-III DSMB compliments study team

The Data Safety Monitoring Board (DSMB) for the CLEAR-III clinical trial met today to review detailed data on the first 175 patients in the trial (152 post Day-180), with additional preliminary data from a total of 251 enrolled patients from across 61 clinical sites. CLEAR-III is a phase III clinical efficacy and outcomes study assessing the effect of external ventricular drainage (EVD) with rt-PA or placebo to treat intraventricular hemorrhage (IVH). The first subject, out of a planned 500, was enrolled in September 2009.

Continue reading
Tags:
OCT
19

Report from the CLEAR-III DSMB Meeting (UPDATED)

[UPDATED 15-Nov] The Data Safety Monitoring Board (DSMB) for the CLEAR III clinical trial met today in both a closed session (to review unblinded data on the first 100 patients without the management team being present) and an open session where they asked questions of the project management and biostatistics teams from the BIOS Coordinating Center at Johns Hopkins. The official letter and a copy of the minutes have now been released and are attached below.

Continue reading
Tags:

MISTIE-3 Site Locations